Study Material | Test Series
Drishti IAS
call1800-121-6260 / 011-47532596
Drishti The Vision Foundation
(A unit of VDK Eduventures Pvt. Ltd.)
mains Test Series 2018
India-Netherlands Sign MoU for Development of Vaccines
Jun 15, 2015

A Memorandum of Understanding was signed between India and Netherlands for development of vaccines. The MoU signed under ‘Make in India’ initiative will enable the Bharat Immunologicals and Biologicals Corporation Ltd (BIBCOL), a Central Public Sector Undertaking to develop Measles-Rubella vaccine at its plant at Chola, Bulandshahr, U.P. 

  • Translational Vaccinology (INTRAVACC) a government-based institute of the Netherlands will extend technical support for the development of vaccine.

  • Cooperation in development of other vaccines and biologicals with DBT Research Institutes shall be explored. 

  • INTRAVACC, an institute which is part of the Ministry of Health, Welfare and Sport of the Netherlands, is internationally renowned for vaccine development and has a long history in technology transfer. 

  • BIBCOL is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science & Technology, Government of India.  

  • BIBCOL was established as a PSU in 1989, with the aim to achieve self-sufficiency for the nation with respect to production and supply of high quality polio vaccine and other biologicals.  

  • BIBCOL has supplied billions of doses of oral polio vaccine to India’s immunisation programme and has played a major role in making India ‘polio free’. 

  • Under the ‘Make in India’ initiative, BIBCOL has embarked on journey to acquire technology and production capabilities for production of Measles-Rubella vaccine with the support of Department of Biotechnology.

  • The cooperation will result in large scale production Measles-Rubella and other needed vaccine of high quality in BIBCOL and save hundreds of thousands of children from the dreaded disease in the country.  

  • In the post-polio eradication era, the focus shall be on elimination/control of other vaccine preventable diseases such as measles and rubella.

This important collaboration between BIBCOL and INTRAVACC will pave the way for manufacture of high quality affordable vaccines, beginning with Measles and Rubella vaccine, and then take on the production of the other needed vaccines for the Immunization Programmes of India and other developing countries in the world.


Helpline Number : 87501 87501
To Subscribe Newsletter and Get Updates.

http://www.drishtiias.com/upsc-current-affairs-article-India-Netherlands-Sign-MoU-for-Development-of-Vaccines